---
search:
  boost: 3
---

# Androgens

This is a subcategory of Endocrine Agents.

## Decision Tree

- [Endocrine Androgens- Non-Preferred Agents (Age Restricted, PA) - Androderm, Testosterone Gel 1%, Testosterone Gel 1% Pump](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUQTc1UVI3REpOOENJMkU4Uk9SNVJNWVYzMiQlQCN0PWcu){ :target="_blank" rel="noopener"}

- [Endocrine - Androgens- Non-Preferred Agents (Age Restricted) - Jatenzo, Methyltestosterone, Natesto, Testopel, Testosterone Cypionate, Testosterone Gel 1.62%, Testosterone Gel 2%, Testosterone Sol 30mg/ACT, Tlando, Xyosted](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNjk0MkRCMVU1MkxZTFlZUjVCUURUWFdGTiQlQCN0PWcu){ :target="_blank" rel="noopener"}

## Formulary

### Preferred

| Preferred                                 | Generic Name | Quantity | Time (Days) |
| :---------------------------------------- | :----------- | :------: | :---------: |
| Androderm <sup>AR PA</sup>                |              |          |             |
| Testosterone Gel 1% <sup>AR PA</sup>      |              |          |             |
| Testosterone Gel 1% Pump <sup>AR PA</sup> |              |          |             |

### Non-Preferred

| Non-Preferred                              | Generic Name | Quantity | Time (Days) |
| :----------------------------------------- | :----------- | :------: | :---------: |
| Jatenzo <sup>AR</sup>                      |              |          |             |
| Methyltestosterone <sup>AR</sup>           |              |          |             |
| Natesto <sup>AR</sup>                      |              |          |             |
| Testopel <sup>AR</sup>                     |              |          |             |
| Testosterone Cypionate <sup>AR</sup>       |              |          |             |
| Testosterone Gel 1.62% <sup>AR</sup>       |              |          |             |
| Testosterone Gel 2% <sup>AR</sup>          |              |          |             |
| Testosterone Sol 30 MG / ACT <sup>AR</sup> |              |          |             |
| Tlando <sup>AR</sup>                       |              |          |             |
| Xyosted <sup>AR</sup>                      |              |          |             |

## Authorizations

**Length of Authorizations**: 365 Days

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Clinical PA

Clinical PA Criteria

-   Must provide documentation of lab work to support the need for testosterone supplementation

### Non-Preferred

Non-Preferred Criteria

-   Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred dug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    -   For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage
-   Must have had an inadequate clinical response of at least ^^90 days^^ with ^^**ALL** preferred^^ drugs
    -   For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    -   For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)
 
[**Gender Dysphoria Criteria](https://special-spoon-f542dccd.pages.github.io/Pharmacist%20Reference%20Guide/Medication%20Guidance/GenderDysphoria/)

### Subsequent Authorization

Subsequent Authorization Criteria

-   Must provide documentation of patientâ€™s clinical response to treatment and ongoing safety monitoring (i.e., testosterone and hematocrit)

**AR** - All drugs: a PA is required for patients younger than 18 years

## Links

[Denial Language (Rph Use Only: Technicians CANNOT deny Prior Authorizations)](https://mygainwell-my.sharepoint.com.mcas.ms/:w:/r/personal/rachel_carpenter_gainwelltechnologies_com/_layouts/15/Doc.aspx?sourcedoc=%7BCD777F63-7F18-4713-8D6A-B043BEE631F5%7D&file=Denial%20Language%20Updated%2009112023.docx&action=embedview&mobileredirect=true&wdStartOn=46&cid=f4472ece-6d4f-4694-b0c5-c150a2f53fea){:target="_blank" rel="noopener"} </br>
[Criteria](https://medicaid.ohio.gov/static/PHM/drug-coverage/20230701+UPDL+Criteria+_v1_FINAL.approved.pdf#page=52){ :target="_blank" rel="noopener"} </br>
[Preferred Drug List](https://medicaid.ohio.gov/static/PHM/drug-coverage/20230701_UPDL_FINAL_ODM.approved.v2.pdf#page=20){ :target="_blank" rel="noopener"} </br>
[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf){ :target="_blank" rel="noopener"}
